Badgley Phelps Wealth Managers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Sell
15,550
-65
-0.4% -$14K 0.07% 144
2026
Q1
$3.4M Buy
15,615
+999
+7% +$222K 0.07% 144
2025
Q4
$3.34M Buy
14,616
+106
+0.7% +$24.1K 0.06% 149
2025
Q3
$3.36M Sell
14,510
-127
-0.9% -$25.9K 0.07% 137
2025
Q2
$2.72M Sell
14,637
-242
-2% -$45K 0.06% 142
2025
Q1
$3.12M Sell
14,879
-103
-0.7% -$20K 0.08% 136
2024
Q4
$2.66M Buy
14,982
+27
+0.2% +$4.96K 0.06% 138
2024
Q3
$2.95M Buy
14,955
+89
+0.6% +$16.6K 0.07% 132
2024
Q2
$2.55M Sell
14,866
-65
-0.4% -$10.8K 0.06% 134
2024
Q1
$2.72M Sell
14,931
-230
-2% -$39.6K 0.07% 127
2023
Q4
$2.35M Buy
15,161
+593
+4% +$86.5K 0.06% 126
2023
Q3
$2.17M Sell
14,568
-389
-3% -$57.1K 0.07% 122
2023
Q2
$2.02M Buy
14,957
+10,617
+245% +$1.56M 0.07% 127
2023
Q1
$692K Buy
4,340
+275
+7% +$42K 0.03% 140
2022
Q4
$657K Buy
4,065
+377
+10% +$57.8K 0.03% 140
2022
Q3
$495K Buy
3,688
+165
+5% +$23.7K 0.02% 139
2022
Q2
$540K Buy
3,523
+975
+38% +$149K 0.02% 142
2022
Q1
$413K Buy
2,548
+358
+16% +$52K 0.01% 163
2021
Q4
$296K Sell
2,190
-695
-24% -$82.1K 0.01% 183
2021
Q3
$311K Buy
+2,885
New +$330K 0.01% 180

Other funds holding ABBV

Badgley Phelps Wealth Managers's ABBV Position: Q2 2026 in Review

Badgley Phelps Wealth Managers reduced its AbbVie (ABBV) stake by 0.42% in Q2 2026, selling an estimated $14K and leaving 15,550 shares worth $3.91M. The position accounts for 0.07% of the portfolio, ranked #144.

Badgley Phelps Wealth Managers first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Badgley Phelps Wealth Managers held 15,550 shares of AbbVie worth $3.91M as of Q2 2026.
  • Badgley Phelps Wealth Managers sold 65 AbbVie shares in Q2 2026, an estimated $14K.
  • AbbVie made up 0.07% of Badgley Phelps Wealth Managers's portfolio in Q2 2026, its #144 holding.
  • Badgley Phelps Wealth Managers first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Badgley Phelps Wealth Managers's 13F filing for Q2 2026, filed 31 Jul 2026.